Mode
Home
Research
Clinical Trials Drug Pipeline Weekly Digests
Reference
Conditions Medications
Community
Questions
Text Size
Log in / Sign up
N/A N=104 Randomized Single-blind Treatment

Physical Activity and Participation

Type 2 Diabetes Mellitus

Bottom Line

View on ClinicalTrials.gov: NCT02268916 ↗
Enrolled (actual)
104
Serious AEs
0.0%
Results posted
Sep 2022
Primary outcome: Primary: Physical Activity — 401.88; -263.81 KCal/week — p==0.18

Study Design & Population

Study type
Interventional
Phase
N/A
Interventions
Counseling (Behavioral); Usual education (Behavioral)
Age
Adult, Older Adult · 60+ yrs
Sex
All
Sponsor
VA Office of Research and Development
Primary completion
Dec 2019

Outcome Measures

OutcomeResultp-value
PRIMARY
Physical Activity		 401.88; -263.81 =0.18
PRIMARY
Social Participation		 0.18; 0.63; 0.35; 0.85; -0.55; -0.36 0.19

Summary

The purpose of the study is to investigate if the investigators can improve physical activity and social participation level among Veterans with diabetes.

Eligibility Criteria

Inclusion Criteria

  • Veterans
  • Aged 60 years or older
  • Has Type 2 diabetes mellitus
  • Able to operate accelerometer
  • Competent to consent to the study
  • No dementia diagnosis
  • Ambulatory with or without assistive device
  • English-speaking
  • Community living (i.e., not a nursing home resident)
  • Not physically active on a regular basis (less than 150 minutes of moderate or vigorous physical activity per week)

Exclusion Criteria

  • Medically unstable
  • Hospitalized within the last 6 months
  • 2 or more days of complete bed rest in the last month
  • hemiplegia or limb amputation
  • Self-reported illness or conditions that would impair the cooperation with the study team or the ability to complete the study
  • work involved in shift schedule
  • current enrollment of a physical activity program
  • replacement of hip or knee within the last 6 months.
  • Parkinson's disease
  • frequent falls
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT02268916). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.

Back to search